Malignant pleural effusion, current and evolving approaches for its diagnosis and management.
暂无分享,去创建一个
[1] F. Rodríguez‐Panadero,et al. Survival and talc pleurodesis in metastatic pleural carcinoma, revisited. Report of 125 cases. , 1993, Chest.
[2] J. Ruckdeschel. Management of malignant pleural effusions. , 1995, Seminars in oncology.
[3] V. Villena,et al. Diagnostic value of CA 549 in pleural fluid. Comparison with CEA, CA 15.3 and CA 72.4. , 2003, Lung cancer.
[4] A. Mariano,et al. New approaches in the diagnostic procedure of malignant pleural effusions. , 2004, Oncology reports.
[5] J. Woodring. Recognition of pleural effusion on supine radiographs: how much fluid is required? , 1984, AJR. American journal of roentgenology.
[6] A. Crnjac. The significance of thoracoscopic mechanical pleurodesis for the treatment of malignant pleural effusions. , 2004, Wiener klinische Wochenschrift.
[7] D. Hicklin,et al. Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[8] D. Allred,et al. Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma. , 1993, Human pathology.
[9] M. J. Schiff,et al. Outpatient pleurodesis of malignant pleural effusions using a small-bore pigtail catheter. , 2000, Chest.
[10] E. Neville,et al. BTS guidelines for the management of malignant pleural effusions. , 2003, Thorax.
[11] P. Goldstraw,et al. Management of recurrent malignant pleural effusions. The complementary role of talc pleurodesis and pleuroperitoneal shunting , 1995, Cancer.
[12] V. Indumathi,et al. A comparative study of pleurodesis using talc slurry and bleomycin in the management of malignant pleural effusions , 2000, Respirology.
[13] V. Foresti. Intrapleural Corynebacterium parvum for recurrent malignant pleural effusions. , 1995, Respiration; international review of thoracic diseases.
[14] N. Sneige,et al. Detection of numerical aberrations of chromosomes 7 and 9 in cytologic specimens of pleural malignant mesothelioma , 2003, Cancer.
[15] J. Aparicio,et al. Malignant Pleural Effusion: Prognostic Factors for Survival and Response to Chemical Pleurodesis in a Series of 120 Cases , 1998, Respiration.
[16] W. Hsu,et al. Ultrasound-guided small-bore Elecath tube insertion for the rapid sclerotherapy of malignant pleural effusion. , 1998, Japanese journal of clinical oncology.
[17] S. Sahn,et al. Talc pleurodesis for the treatment of pneumothorax and pleural effusion. , 1994, Chest.
[18] F. Rey,et al. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. , 1995, Chest.
[19] P. Eng,et al. Pleural changes in malignant pleural effusions: appearance on computed tomography. , 1994, Cleveland Clinic journal of medicine.
[20] W. Parulekar,et al. Use of small-bore vs large-bore chest tubes for treatment of malignant pleural effusions. , 2001, Chest.
[21] R. Light,et al. Comparing transforming growth factor‐β2, talc and bleomycin as pleurodesing agents in sheep , 2002, Respirology.
[22] F. Rodríguez‐Panadero. Malignant pleural diseases. , 2000, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.
[23] A. Nana,et al. The efficacy of doxycycline as a pleural sclerosing agent in malignant pleural effusion: A prospective study , 1996, Respirology.
[24] S. Sahn,et al. Carcinomatous involvement of the pleura: an analysis of 96 patients. , 1977, The American journal of medicine.
[25] D. Marmé,et al. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease , 1999, Cancer.
[26] J. Seidman,et al. Clinical Experience With Tetracycline Pleurodesis of Malignant Pleural Effusions , 1987, Southern medical journal.
[27] S. Sahn,et al. State of the art. The pleura. , 1988, The American review of respiratory disease.
[28] F. Gleeson,et al. Intrapleural streptokinase in the management of malignant multiloculated pleural effusions. , 1999, Chest.
[29] P. Astoul,et al. Intrapleural immunotherapy with escalating doses of interleukin‐2 in metastatic pleural effusions , 1993, Cancer.
[30] C. Feo,et al. [The ideal length of hospital stay in the surgical treatment of colorectal cancer]. , 2002, Annali italiani di chirurgia.
[31] V. Raptopoulos,et al. Complications associated with thoracentesis. A prospective, randomized study comparing three different methods. , 1990, Archives of internal medicine.
[32] M. Charbonneau,et al. Thoracoscopy for the diagnosis of pleural disease. , 1991, Annals of internal medicine.
[33] R. Perng,et al. The role of fiberoptic bronchoscopy in evaluating the causes of pleural effusions. , 1989, Archives of internal medicine.
[34] P. Moulder,et al. Iodized talc pleurodesis for the treatment of pleural effusions. , 1992, The Journal of thoracic and cardiovascular surgery.
[35] A. Yim. Port-site recurrence following video-assisted thoracoscopic surgery , 1995, Surgical Endoscopy.
[36] A. Cantó,et al. Points to consider when choosing a biopsy method in cases of pleurisy of unknown origin. , 1983, Chest.
[37] S J Mentzer,et al. Malignant effusive disease of the pleura and pericardium. , 1997, Chest.
[38] M. Votaw,et al. Pleural effusion in multiple myeloma , 1979, Cancer.
[39] P. Rubin,et al. The management of pleural effusions and chylothorax in lymphoma. , 1965, Radiology.
[40] A. Bernard,et al. Early and late mortality after pleurodesis for malignant pleural effusion. , 2002, The Annals of thoracic surgery.
[41] A. Dekker,et al. Diagnostic value of DNA analysis in effusions by flow cytometry and image analysis. A prospective study on 102 patients as compared with cytologic examination. , 1991, American journal of clinical pathology.
[42] R. Livingston,et al. Isolated pleural effusion in small cell lung carcinoma: favorable prognosis. A review of the Southwest Oncology Group experience. , 1982, Chest.
[43] C. Kardinal,et al. Pleural effusion in breast carcinoma: Analysis of 122 cases , 1981, Cancer.
[44] D. Tassinari,et al. Prospective randomized trial of intrapleural bleomycin versus interferon alfa-2b via ultrasound-guided small-bore chest tube in the palliative treatment of malignant pleural effusions. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[45] L. Valdés,et al. The etiology of pleural effusions in an area with high incidence of tuberculosis. , 1996, Chest.
[46] A. Chella,et al. [Treatment of malignant pleural effusion by percutaneous catheter drainage and chemical pleurodesis]. , 1994, Minerva chirurgica.
[47] P. Goldstraw,et al. The long-term morbidity of pleuroperitoneal shunts in the management of recurrent malignant effusions. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[48] S. Sahn,et al. Management of malignant pleural effusions. , 2001, The European respiratory journal.
[49] A. Ardizzoni,et al. Intrapleural natural beta interferon in the treatment of malignant pleural effusions. , 1988, Oncology.
[50] K. Kovitz,et al. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions , 1999, Cancer.
[51] S. Sahn,et al. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer. , 2004, Chest.
[52] I. Silverberg. Management of effusions. , 1970, Oncology.
[53] J. Aparicio,et al. Pleurodesis in malignant pleural effusions: a randomized study of tetracycline versus bleomycin. , 1997, The European respiratory journal.
[54] D. Alberts,et al. Bleomycin pharmacokinetics in man. II. Intracavitary administration. , 1979, Cancer chemotherapy and pharmacology.
[55] A. Catania,et al. Volume‐regulated Cl− channels in human pleural mesothelioma cells , 2004, FEBS letters.
[56] Sahn Sa. Pleural diagnostic techniques. , 1995 .
[57] G. Hillerdal,et al. The impact of pleurodesis in malignant effusion on respiratory function. , 1999, Respiratory medicine.
[58] D. Nauffal,et al. Effect of thoracentesis on pulmonary gas exchange. , 1983, Thorax.
[59] V. Rusch,et al. Pleurodesis using talc slurry. , 1994, Chest.
[60] P. E. Cardoso,et al. Thoracoscopy talc poudrage : a 15-year experience. , 2001, Chest.
[61] J. Norum,et al. Intrapleurally instilled mitoxantrone in metastatic pleural effusions: a phase II study. , 1997, Journal of chemotherapy.
[62] A. DeMaria,et al. Diagnostic, Prognostic and Therapeutic Implications , 1974 .
[63] S. Sahn,et al. Tuberculous pleurisy is more common in AIDS than in non-AIDS patients with tuberculosis. , 1997, Chest.
[64] Y. Aelony. Dry talc pleurodesis via chest tube. , 2003, Chest.
[65] E. Wiley,et al. Evaluation of breast cancer metastases in pleural effusions by molecular biology techniques , 2002, Diagnostic cytopathology.
[66] W. Wilmanns,et al. P53-immunoreactive cells in benign and malignant effusions: diagnostic value using a panel of monoclonal antibodies and comparison with CEA-staining. , 1999, Oncology reports.
[67] A. Gaudichet,et al. Acute pneumonitis with bilateral pleural effusion after talc pleurodesis. , 1984, Chest.
[68] R. Light. Management of pleural effusions. , 2000, Journal of the Formosan Medical Association = Taiwan yi zhi.
[69] E. Montserrat,et al. Characteristics and prognostic value of pleural effusions in non-Hodgkin's lymphomas. , 1985, European journal of respiratory diseases.
[70] S. Barni,et al. Progress Report on the Palliative Therapy of 100 Patients with Neoplastic Effusions by Intracavitary Low-Dose Interleukin-2 , 2001, Oncology.
[71] U. Prakash,et al. Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases. , 1985, Mayo Clinic proceedings.
[72] J. Heffner,et al. Multilevel likelihood ratios for identifying exudative pleural effusions(*). , 2002, Chest.
[73] M. Bains,et al. Indications for pleurectomy in malignant effusion , 1975, Cancer.
[74] J. Alegre,et al. Polymorphonuclear Elastase in the Early Diagnosis of Complicated Pyogenic Pleural Effusions , 2003, Respiration.
[75] H. Ngan,et al. Mitomycin chemotherapeutic pleurodesis to palliate malignant pleural effusions secondary to gynecological cancer , 1999, Acta obstetricia et gynecologica Scandinavica.
[76] P. Godley,et al. Major hemorrhage following administration of intrapleural streptokinase. , 1984, Chest.
[77] F. Hausheer,et al. Diagnosis and treatment of malignant pleural effusion , 1985, Cancer and Metastasis Reviews.
[78] M. Neri,et al. Serum anti-p53 autoantibodies in pleural malignant mesothelioma, lung cancer and non-neoplastic lung diseases. , 2003, Lung cancer.
[79] T. L. Svendsen,et al. Treatment of malignant pleural effusion with drainage, with and without instillation of talc. , 1984, European journal of respiratory diseases.
[80] N. Barbetakis,et al. Results of chemical pleurodesis with mitoxantrone in malignant pleural effusion from breast cancer , 2004, World journal of surgical oncology.
[81] D. Weissberg,et al. Talc pleurodesis : experience with 360 patients , 1993 .
[82] T. Daniel. Diagnostic thoracoscopy for pleural disease. , 1993, The Annals of thoracic surgery.
[83] K. Kesler,et al. Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions. , 1993, The Journal of thoracic and cardiovascular surgery.
[84] J. Heffner,et al. Clinical efficacy of doxycycline for pleurodesis. , 1994, Chest.
[85] J. Herndon,et al. Sclerotherapy for malignant pleural effusions: a prospective randomized trial of bleomycin vs doxycycline with small-bore catheter drainage. , 1998, Chest.
[86] W. Fry,et al. Parietal pleurectomy for malignant pleural effusion , 1995, Annals of Surgical Oncology.
[87] R. Light. Useful tests on the pleural fluid in the management of patients with pleural effusions. , 1999, Current opinion in pulmonary medicine.
[88] F. Rodríguez‐Panadero. Talc pleurodesis for treating malignant pleural effusions. , 1995, Chest.
[89] J. M. Tura,et al. Talc preparations used for pleurodesis vary markedly from one preparation to another. , 2001, Chest.
[90] R. Light,et al. Vascular endothelial growth factor level correlates with transforming growth factor-beta isoform levels in pleural effusions. , 2000, Chest.
[91] K. Takazawa,et al. [Adult case of isolated noncompaction of left ventricular myocardium revealed at hospitalization for tuberculous pleuritis]. , 1999, Journal of cardiology.
[92] D. Sugarbaker,et al. Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability. , 1992, AJR. American journal of roentgenology.
[93] S. Sahn. Use of fibrinolytic agents in the management of complicated parapneumonic effusions and empyemas , 1998, Thorax.
[94] Y. Aelony,et al. Thoracoscopic talc poudrage in malignant pleural effusions: effective pleurodesis despite low pleural pH. , 1998, Chest.
[95] P. Astoul,et al. Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases. , 1996, Chest.
[96] E. Patz,et al. Ambulatory sclerotherapy for malignant pleural effusions. , 1996, Radiology.
[97] D. Thickett,et al. Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. , 2001, American journal of respiratory and critical care medicine.
[98] I. Fentiman,et al. Pleural effusion in breast cancer: A review of 105 cases , 1981, Cancer.
[99] M. Orringer,et al. Statement of the AATS/STS Joint Committee on Thoracoscopy and Video Assisted Thoracic Surgery. , 1992, Journal of Thoracic and Cardiovascular Surgery.
[100] W. Johnston. The malignant pleural effusion. A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients , 1985, Cancer.
[101] R. Loddenkemper. Thoracoscopy--state of the art. , 1998, The European respiratory journal.
[102] S. Sahn,et al. Chemical Pleurodesis for Malignant Pleural Effusions , 1994, Annals of Internal Medicine.
[103] H. Magnussen,et al. Intrapleural palliative treatment of malignant pleural effusions with mitoxantrone versus placebo (pleural tube alone). , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.
[104] H. Bayram,et al. Comparison of the Effectiveness of Some Pleural Sclerosing Agents Used for Control of Effusions in Malignant Pleural Mesothelioma: A Review of 117 Cases , 2000, Respiration.
[105] R. Cerfolio,et al. Video-assisted thoracoscopic surgery using single-lumen endotracheal tube anesthesia. , 2004, Chest.
[106] T B Ferguson,et al. The treatment of malignant pleural effusions , 1974, Cancer.
[107] S. Sahn,et al. Pleural fluid pH in malignant effusions. Diagnostic, prognostic, and therapeutic implications. , 1988, Annals of internal medicine.
[108] D. Skinner,et al. Pleuro–peritoneal Shunting: Alternative Therapy for Pleural Effusions , 1988, Annals of surgery.
[109] J. Heffner,et al. Tetracycline pleurodesis. Adios, farewell, adieu. , 1992, Chest.
[110] J. Beamis,et al. Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions. , 1994, Thorax.
[111] E. Scalzetti,et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. , 2005, Chest.
[112] Cytologic effects of photodynamic therapy in body fluids , 1996, Diagnostic cytopathology.